Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in a Chinese Cohort: Comparison with SLEDAI-2-K
Rheumatology and Therapy · 2026-06 · 13 (3) · 563-580
DOI: 10.1007/s40744-026-00832-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology and Therapy, online erschienen am 09.03.2026. Verfasst von Tingting Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Peking University First Hospital, No.8, Xishiku Street, West District, Beijing, 100034, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National High-Level Hospital Clinical Research Funding, Key Program of Major Research Plan of the National Natural Science Foundation of China.
Abstract (Originalsprache)
INTRODUCTION: Accurate assessment of disease activity in systemic lupus erythematosus (SLE) remains a persistent challenge. We aimed to validate the SLE disease activity score (SLE-DAS) in Chinese patients. METHODS: We analyzed the agreement between SLE-DAS and SLEDAI-2 K using our prospective STAR cohort. Construct validity was assessed through correlations with physician global assessment (PGA), as well as through known-group discrimination (PGA-cut off ≥ 1 for active). Factors associated with classification discordance and the association between baseline SLE-DAS and 12-month organ damage accrual were assessed using logistic regression. RESULTS: Among 507 SLE patients, SLE-DAS demonstrated strong correlations with PGA (r = 0.726, P < 0.001) and SLEDAI-2 K (r = 0.750, P < 0.001), with an overall agreement of 83.0% between SLE-DAS and SLEDAI-2 K. Both instruments demonstrated comparable discriminative power for active disease (SLE-DAS AUC = 0.832; SLEDAI-2 K AUC = 0.860). Among 211 patients with mild disease activity classified by SLEDAI-2 K, 61 were reclassified into higher categories by SLE-DAS. These patients exhibited higher PGA (0.8 ± 1.0 vs. 0.3 ± 0.7; P < 0.001) and glucocorticoid doses (25.7 ± 22.3 vs. 11.3 ± 15.5; P < 0.001) than those with concordant classifications. Lupus nephritis (45.9% vs. 18.0%; P < 0.001) and hematological involvement (32.8% vs. 18.0%; P = 0.020) were more frequent in them. We identified that nephritis (OR = 4.57, 95% CI 2.18-9.57, P < 0.001) and hematological involvement (OR = 2.76, 95% CI 1.27-6.02, P = 0.011) were associated with classification discordance. Baseline SLE-DAS was positively associated with SLE SLICC/ACR Damage Index (SDI) accrual at 12 months of follow-up (OR = 1.38, P = 0.038). CONCLUSIONS: SLE-DAS demonstrates superior accuracy in assessing disease activity compared to SLEDAI-2 K, likely attributable to refinements in assessing nephritis and hematological manifestations. Baseline SLE-DAS also exhibited a positive association with short-term organ damage accrual, though long-term validation is required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Peking University First Hospital, No.8, Xishiku Street, West District, Beijing, 100034, China.
- Department of Rheumatology and Clinical Immunology, Peking University First Hospital, No.8, Xishiku Street, West District, Beijing, 100034, China. zhuoli.zhang@126.com.
Förderung
- National High-Level Hospital Clinical Research Funding
- Key Program of Major Research Plan of the National Natural Science Foundation of China
Zitieren
APA
Ding, T., Li, Y., Gao, D., Ji, L., Zhang, X., & Zhang, Z. (2026). Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in a Chinese Cohort: Comparison with SLEDAI-2-K. Rheumatology and Therapy, 13(3), 563-580. https://doi.org/10.1007/s40744-026-00832-7
Vancouver
Ding T, Li Y, Gao D, Ji L, Zhang X, Zhang Z. Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in a Chinese Cohort: Comparison with SLEDAI-2-K. Rheumatology and Therapy. 2026;13(3):563-580. doi:10.1007/s40744-026-00832-7
BibTeX
@article{Ding2026,
author = {Ding, Tingting and Li, Yamin and Gao, Dai and Ji, Lanlan and Zhang, Xiaohui and Zhang, Zhuoli},
title = {Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in a Chinese Cohort: Comparison with SLEDAI-2-K},
journal = {Rheumatology and Therapy},
year = {2026},
volume = {13},
number = {3},
pages = {563--580},
doi = {10.1007/s40744-026-00832-7}
}
EUVIMED